BioNTech, Pfizer develop experimental vaccine against Covid-19

Source : 112 Ukraine

It could reach the markets by late 2020
09:31, 6 May 2020

Open source

German enterprise BioNTech and American company Pfizer have jointly developed an experimental vaccine against coronavirus. There's a chance it could reach the world's markets by the end of the year. Ugur Şahin, the BioNTech CEO said so in an interview with CNN.

“We see vaccine responses, we see strong vaccine responses at even low doses. And we believe that this vaccine response since we have seen that in different animal models will also translate into vaccine responses in human subjects," the official said.

The vaccine is already being tested on people in the U.S. and Germany.

Related: Israel announced the creation of universal flu vaccine

According to Şahin, if the vaccine is approved by the governing authorities, partner companies will be ready to speed up its production and entrance to markets so that it becomes available for the population.

"Şahin believes Covid-19 will be responsive to a vaccine which is he calls the “most important aspect” of vaccine development. He said the second aspect is the “very encouraging” pre-clinical data," CNN wrote.

Related: Trump expects US to have COVID-19 vaccine by end of year


Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more